{"transactions":[{"id":4630893,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20769,"kind":"person","name":"Guerard Frederic","position":1,"cik":"0001825009","reported_name":"Guerard Frederic","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2026-10-05T21:24:00.000Z","date":"2026-10-01","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Beginning August 19, 2026, 1/12th of the shares subject to the option vest in equal monthly installments over a one year period, provided that the option will in any case be fully vested on the date of the 2027 annual meeting of stockholders of CalciMedica, Inc."}],"balance_after":20000,"derivative":{"exercise_price":1.64,"expiration_date":"2036-09-30","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001825009-26-000003","document":"form4-10052026_091056.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1825009/000182500926000003/form4-10052026_091056.xml","form_type":"4"}},{"id":678565,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20769,"kind":"person","name":"Guerard Frederic","position":1,"cik":"0001825009","reported_name":"Guerard Frederic","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2026-08-21T22:45:54.000Z","date":"2026-08-19","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the shares subject to the option vest in equal monthly installments over a one year period following the date of grant, provided that the option will in any case be fully vested on the date of the 2027 annual meeting of stockholders of CalciMedica, Inc."}],"balance_after":10000,"derivative":{"exercise_price":0.6131,"expiration_date":"2036-08-18","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001825009-26-000002","document":"form4-08212026_100850.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000182500926000002/form4-08212026_100850.xml","form_type":"4"}},{"id":737899,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":20769,"kind":"person","name":"Guerard Frederic","position":1,"cik":"0001825009","reported_name":"Guerard Frederic","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-16T00:18:01.000Z","date":"2026-06-15","kind":"grant","planned":false,"acquired":true,"shares":22100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be an Outside Director (as defined in the Issuer's Outside Director Compensation Policy) through such applicable date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier to occur of June 15, 2027 or the date of the next annual meeting of stockholders."}],"balance_after":22100,"derivative":{"exercise_price":6.63,"expiration_date":"2036-06-15","underlying":"Common Stock","underlying_shares":22100},"source":{"system":"sec-edgar","filing":"0001825009-26-000001","document":"wk-form4_1781569078.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000182500926000001/wk-form4_1781569078.xml","form_type":"4"}},{"id":1100863,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20769,"kind":"person","name":"Guerard Frederic","position":1,"cik":"0001825009","reported_name":"Guerard Frederic","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-06-26T22:25:13.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/12th of the shares subject to the option vest in equal monthly installments over a one year period following June 24, 2025, provided that the shares will in any case be fully vested on the date of Company's 2026 annual meeting of stockholders"}],"balance_after":10000,"derivative":{"exercise_price":1.65,"expiration_date":"2035-06-23","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001415889-25-018304","document":"form4-06262025_100609.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000141588925018304/form4-06262025_100609.xml","form_type":"4"}},{"id":1100862,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20769,"kind":"person","name":"Guerard Frederic","position":1,"cik":"0001825009","reported_name":"Guerard Frederic","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-06-26T22:25:13.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option grant was approved by the Board of Directors of CalciMedica, Inc. (the \"Company\") on April 23, 2025, subject to stockholder approval of an amendment of the Company's 2023 Equity Incentive Plan (the \"Amended 2023 EIP\") under which the option was granted. The Company's stockholders approved the Amended 2023 EIP on June 24, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/9th of the shares subject to the option vest in equal monthly installments over a one year period following April 1, 2025."}],"balance_after":15000,"derivative":{"exercise_price":1.53,"expiration_date":"2035-04-22","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001415889-25-018304","document":"form4-06262025_100609.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000141588925018304/form4-06262025_100609.xml","form_type":"4"}},{"id":1100861,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20769,"kind":"person","name":"Guerard Frederic","position":1,"cik":"0001825009","reported_name":"Guerard Frederic","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-06-26T22:25:13.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option grant was approved by the Board of Directors of CalciMedica, Inc. (the \"Company\") on April 23, 2025, subject to stockholder approval of an amendment of the Company's 2023 Equity Incentive Plan (the \"Amended 2023 EIP\") under which the option was granted. The Company's stockholders approved the Amended 2023 EIP on June 24, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Immediately exercisable."}],"balance_after":5000,"derivative":{"exercise_price":1.53,"expiration_date":"2035-04-22","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001415889-25-018304","document":"form4-06262025_100609.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000141588925018304/form4-06262025_100609.xml","form_type":"4"}},{"id":1100860,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20769,"kind":"person","name":"Guerard Frederic","position":1,"cik":"0001825009","reported_name":"Guerard Frederic","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-06-26T22:25:13.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option grant was approved by the Board of Directors of CalciMedica, Inc. (the \"Company\") on April 23, 2025, subject to stockholder approval of an amendment of the Company's 2023 Equity Incentive Plan (the \"Amended 2023 EIP\") under which the option was granted. The Company's stockholders approved the Amended 2023 EIP on June 24, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/12th of the shares subject to the option vest in equal monthly installments over a one year period following March 26, 2025."}],"balance_after":10000,"derivative":{"exercise_price":1.53,"expiration_date":"2035-04-22","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001415889-25-018304","document":"form4-06262025_100609.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000141588925018304/form4-06262025_100609.xml","form_type":"4"}},{"id":1115128,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":20769,"kind":"person","name":"Guerard Frederic","position":1,"cik":"0001825009","reported_name":"Guerard Frederic","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-11T21:46:24.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":13500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be an Outside Director (as defined in the Issuer's Outside Director Compensation Policy) through such applicable date, one hundred percent (100%) of the shares subject to the option shall vest on June 11, 2026."}],"balance_after":13500,"derivative":{"exercise_price":30,"expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":13500},"source":{"system":"sec-edgar","filing":"0001815776-25-000046","document":"wk-form4_1749678377.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000181577625000046/wk-form4_1749678377.xml","form_type":"4"}},{"id":1420625,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20769,"kind":"person","name":"Guerard Frederic","position":1,"cik":"0001825009","reported_name":"Guerard Frederic","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2024-08-28T23:14:57.000Z","date":"2024-08-27","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the shares subject to the option vest in equal monthly installments over a one year period following March 28, 2024."}],"balance_after":10000,"derivative":{"exercise_price":4.16,"expiration_date":"2034-08-26","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001415889-24-022509","document":"form4-08282024_110854.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000141588924022509/form4-08282024_110854.xml","form_type":"4"}},{"id":1537443,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20769,"kind":"person","name":"Guerard Frederic","position":1,"cik":"0001825009","reported_name":"Guerard Frederic","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2024-04-23T01:53:21.000Z","date":"2024-03-28","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the shares subject to the option vest in equal monthly installments over a one year period following the date of grant."}],"balance_after":10000,"derivative":{"exercise_price":4.16,"expiration_date":"2034-03-27","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001415889-24-011354","document":"form4-04232024_010415.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000141588924011354/form4-04232024_010415.xml","form_type":"4"}},{"id":1561967,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":20769,"kind":"person","name":"Guerard Frederic","position":1,"cik":"0001825009","reported_name":"Guerard Frederic","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-26T00:40:57.000Z","date":"2024-03-21","kind":"grant","planned":false,"acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2024 Equity Incentive Plan) through each applicable date, one thirty-sixth (1/36th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). \"Vesting Commencement Date\" shall mean March 21, 2024."}],"balance_after":27000,"derivative":{"exercise_price":15.05,"expiration_date":"2034-03-20","underlying":"Common Stock","underlying_shares":27000},"source":{"system":"sec-edgar","filing":"0001815776-24-000027","document":"wk-form4_1711413647.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000181577624000027/wk-form4_1711413647.xml","form_type":"4"}},{"id":1561966,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":20769,"kind":"person","name":"Guerard Frederic","position":1,"cik":"0001825009","reported_name":"Guerard Frederic","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-26T00:40:57.000Z","date":"2024-03-21","kind":"grant","planned":false,"acquired":true,"shares":23571,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Stock option assumed in connection with the closing of the transactions contemplated by the Agreement and Plan of Merger, dated as of November 14, 2023 (the \"Merger Agreement\"), by and among the Issuer, Generate Merger Sub, Inc., a Delaware corporation and wholly-owned subsidiary of the issuer, and LENZ Therapeutics Operations, Inc. (previously named Lenz Therapeutics, Inc.), a Delaware corporation (\"LENZ OpCo\"), in exchange of an outstanding option to purchase shares of LENZ OpCo, pursuant to the terms and conditions of the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the LENZ Therapeutics Operations, Inc. (previously named Lenz Therapeutics, Inc.) 2020 Equity Incentive Plan)  through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). \"Vesting Commencement Date\" shall mean March 6, 2023."}],"balance_after":23571,"derivative":{"exercise_price":6.04,"expiration_date":"2033-06-19","underlying":"Common Stock","underlying_shares":23571},"source":{"system":"sec-edgar","filing":"0001815776-24-000027","document":"wk-form4_1711413647.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000181577624000027/wk-form4_1711413647.xml","form_type":"4"}},{"id":1561965,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":20769,"kind":"person","name":"Guerard Frederic","position":1,"cik":"0001825009","reported_name":"Guerard Frederic","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-26T00:40:57.000Z","date":"2024-03-21","kind":"grant","planned":false,"acquired":true,"shares":30897,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Stock option assumed in connection with the closing of the transactions contemplated by the Agreement and Plan of Merger, dated as of November 14, 2023 (the \"Merger Agreement\"), by and among the Issuer, Generate Merger Sub, Inc., a Delaware corporation and wholly-owned subsidiary of the issuer, and LENZ Therapeutics Operations, Inc. (previously named Lenz Therapeutics, Inc.), a Delaware corporation (\"LENZ OpCo\"), in exchange of an outstanding option to purchase shares of LENZ OpCo, pursuant to the terms and conditions of the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the LENZ Therapeutics Operations, Inc. (previously named Lenz Therapeutics, Inc.) 2020 Equity Incentive Plan)  through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). \"Vesting Commencement Date\" shall mean September 17, 2021."}],"balance_after":30897,"derivative":{"exercise_price":2.08,"expiration_date":"2031-09-16","underlying":"Common Stock","underlying_shares":30897},"source":{"system":"sec-edgar","filing":"0001815776-24-000027","document":"wk-form4_1711413647.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000181577624000027/wk-form4_1711413647.xml","form_type":"4"}},{"id":1937690,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20769,"kind":"person","name":"Guerard Frederic","position":1,"cik":"0001825009","reported_name":"Guerard Frederic","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2023-03-27T23:57:38.000Z","date":"2023-03-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":83705,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects a 14-to-1 reverse stock split effective March 17, 2023. Under the terms of the Agreement and Plan of Merger and Reorganization, dated as of November 21, 2022, as amended (the \"Merger Agreement\"), by and among CalciMedica, Inc. (\"Private CalciMedica\"), the Issuer and Camaro Merger Sub, Inc., a wholly-owned subsidiary of the Issuer (\"Merger Sub\"), on March 20, 2023, Merger Sub merged with and into Private CalciMedica (the \"Merger\"), with Private CalciMedica surviving the Merger as a wholly-owned subsidiary of the Issuer. Upon the closing of the Merger, each share of CalciMedica common capital stock was converted into the right to receive 0.0288 of a share of the Issuer's common stock. Subsequent to the Merger, the name of the Issuer was changed from Graybug Vision, Inc. to CalciMedica, Inc. In connection with the Merger, the vesting of Frederic Guerard's options and restricted stock units (\"RSUs\") were fully accelerated and the RSUs were settled on March 23, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a 14-to-1 reverse stock split effective March 17, 2023. Under the terms of the Agreement and Plan of Merger and Reorganization, dated as of November 21, 2022, as amended (the \"Merger Agreement\"), by and among CalciMedica, Inc. (\"Private CalciMedica\"), the Issuer and Camaro Merger Sub, Inc., a wholly-owned subsidiary of the Issuer (\"Merger Sub\"), on March 20, 2023, Merger Sub merged with and into Private CalciMedica (the \"Merger\"), with Private CalciMedica surviving the Merger as a wholly-owned subsidiary of the Issuer. Upon the closing of the Merger, each share of CalciMedica common capital stock was converted into the right to receive 0.0288 of a share of the Issuer's common stock. Subsequent to the Merger, the name of the Issuer was changed from Graybug Vision, Inc. to CalciMedica, Inc. In connection with the Merger, the vesting of Frederic Guerard's options and restricted stock units (\"RSUs\") were fully accelerated and the RSUs were settled on March 23, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reflects a 14-to-1 reverse stock split effective March 17, 2023. Under the terms of the Agreement and Plan of Merger and Reorganization, dated as of November 21, 2022, as amended (the \"Merger Agreement\"), by and among CalciMedica, Inc. (\"Private CalciMedica\"), the Issuer and Camaro Merger Sub, Inc., a wholly-owned subsidiary of the Issuer (\"Merger Sub\"), on March 20, 2023, Merger Sub merged with and into Private CalciMedica (the \"Merger\"), with Private CalciMedica surviving the Merger as a wholly-owned subsidiary of the Issuer. Upon the closing of the Merger, each share of CalciMedica common capital stock was converted into the right to receive 0.0288 of a share of the Issuer's common stock. Subsequent to the Merger, the name of the Issuer was changed from Graybug Vision, Inc. to CalciMedica, Inc. In connection with the Merger, the vesting of Frederic Guerard's options and restricted stock units (\"RSUs\") were fully accelerated and the RSUs were settled on March 23, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Reflects a 14-to-1 reverse stock split effective March 17, 2023. Under the terms of the Agreement and Plan of Merger and Reorganization, dated as of November 21, 2022, as amended (the \"Merger Agreement\"), by and among CalciMedica, Inc. (\"Private CalciMedica\"), the Issuer and Camaro Merger Sub, Inc., a wholly-owned subsidiary of the Issuer (\"Merger Sub\"), on March 20, 2023, Merger Sub merged with and into Private CalciMedica (the \"Merger\"), with Private CalciMedica surviving the Merger as a wholly-owned subsidiary of the Issuer. Upon the closing of the Merger, each share of CalciMedica common capital stock was converted into the right to receive 0.0288 of a share of the Issuer's common stock. Subsequent to the Merger, the name of the Issuer was changed from Graybug Vision, Inc. to CalciMedica, Inc. In connection with the Merger, the vesting of Frederic Guerard's options and restricted stock units (\"RSUs\") were fully accelerated and the RSUs were settled on March 23, 2023."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":83705},"source":{"system":"sec-edgar","filing":"0001209191-23-021303","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000120919123021303/doc4.xml","form_type":"4"}},{"id":1937689,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20769,"kind":"person","name":"Guerard Frederic","position":1,"cik":"0001825009","reported_name":"Guerard Frederic","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-03-27T23:57:38.000Z","date":"2023-03-23","kind":"tax_withholding","planned":false,"acquired":false,"shares":20383,"price":5.5,"value":112106.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a 14-to-1 reverse stock split effective March 17, 2023. Under the terms of the Agreement and Plan of Merger and Reorganization, dated as of November 21, 2022, as amended (the \"Merger Agreement\"), by and among CalciMedica, Inc. (\"Private CalciMedica\"), the Issuer and Camaro Merger Sub, Inc., a wholly-owned subsidiary of the Issuer (\"Merger Sub\"), on March 20, 2023, Merger Sub merged with and into Private CalciMedica (the \"Merger\"), with Private CalciMedica surviving the Merger as a wholly-owned subsidiary of the Issuer. Upon the closing of the Merger, each share of CalciMedica common capital stock was converted into the right to receive 0.0288 of a share of the Issuer's common stock. Subsequent to the Merger, the name of the Issuer was changed from Graybug Vision, Inc. to CalciMedica, Inc. In connection with the Merger, the vesting of Frederic Guerard's options and restricted stock units (\"RSUs\") were fully accelerated and the RSUs were settled on March 23, 2023."}],"balance_after":90727,"source":{"system":"sec-edgar","filing":"0001209191-23-021303","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000120919123021303/doc4.xml","form_type":"4"}},{"id":1937688,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20769,"kind":"person","name":"Guerard Frederic","position":1,"cik":"0001825009","reported_name":"Guerard Frederic","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-03-27T23:57:38.000Z","date":"2023-03-23","kind":"disposition_to_issuer","planned":false,"acquired":true,"shares":83705,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a 14-to-1 reverse stock split effective March 17, 2023. Under the terms of the Agreement and Plan of Merger and Reorganization, dated as of November 21, 2022, as amended (the \"Merger Agreement\"), by and among CalciMedica, Inc. (\"Private CalciMedica\"), the Issuer and Camaro Merger Sub, Inc., a wholly-owned subsidiary of the Issuer (\"Merger Sub\"), on March 20, 2023, Merger Sub merged with and into Private CalciMedica (the \"Merger\"), with Private CalciMedica surviving the Merger as a wholly-owned subsidiary of the Issuer. Upon the closing of the Merger, each share of CalciMedica common capital stock was converted into the right to receive 0.0288 of a share of the Issuer's common stock. Subsequent to the Merger, the name of the Issuer was changed from Graybug Vision, Inc. to CalciMedica, Inc. In connection with the Merger, the vesting of Frederic Guerard's options and restricted stock units (\"RSUs\") were fully accelerated and the RSUs were settled on March 23, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a 14-to-1 reverse stock split effective March 17, 2023. Under the terms of the Agreement and Plan of Merger and Reorganization, dated as of November 21, 2022, as amended (the \"Merger Agreement\"), by and among CalciMedica, Inc. (\"Private CalciMedica\"), the Issuer and Camaro Merger Sub, Inc., a wholly-owned subsidiary of the Issuer (\"Merger Sub\"), on March 20, 2023, Merger Sub merged with and into Private CalciMedica (the \"Merger\"), with Private CalciMedica surviving the Merger as a wholly-owned subsidiary of the Issuer. Upon the closing of the Merger, each share of CalciMedica common capital stock was converted into the right to receive 0.0288 of a share of the Issuer's common stock. Subsequent to the Merger, the name of the Issuer was changed from Graybug Vision, Inc. to CalciMedica, Inc. In connection with the Merger, the vesting of Frederic Guerard's options and restricted stock units (\"RSUs\") were fully accelerated and the RSUs were settled on March 23, 2023."}],"balance_after":111110,"source":{"system":"sec-edgar","filing":"0001209191-23-021303","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000120919123021303/doc4.xml","form_type":"4"}},{"id":1968398,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20769,"kind":"person","name":"Guerard Frederic","position":1,"cik":"0001825009","reported_name":"Guerard Frederic","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2023-03-07T00:02:23.000Z","date":"2023-03-03","kind":"exercise","acquired":false,"shares":65625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs shall vested as to 6.25% of the total shares on November 16, 2022, and 6.25% of the remaining shares shall vest quarterly thereafter such that the RSUs shall be fully vested on August 16, 2026, subject to the continued service of the Reporting Person to the Issuer through each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs do not expire; they either vest or are canceled prior to vest date."}],"balance_after":918750,"derivative":{"underlying":"Common Stock","underlying_shares":65625},"source":{"system":"sec-edgar","filing":"0001209191-23-016513","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000120919123016513/doc4.xml","form_type":"4"}},{"id":1968397,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20769,"kind":"person","name":"Guerard Frederic","position":1,"cik":"0001825009","reported_name":"Guerard Frederic","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2023-03-07T00:02:23.000Z","date":"2023-03-03","kind":"exercise","acquired":false,"shares":221746,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs shall vested as to 100% of the total RSUs on February 28, 2023 and settled on March 3, 2023, subject to the Reporting Person's provision of service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs do not expire; they either vest or are canceled prior to vest date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":221746},"source":{"system":"sec-edgar","filing":"0001209191-23-016513","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000120919123016513/doc4.xml","form_type":"4"}},{"id":1968396,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20769,"kind":"person","name":"Guerard Frederic","position":1,"cik":"0001825009","reported_name":"Guerard Frederic","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2023-03-07T00:02:23.000Z","date":"2023-03-03","kind":"exercise","acquired":false,"shares":28125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested as to 1/4 of the total shares on May 19, 2022, and 1/16 of the remaining shares shall vest quarterly thereafter such that the RSUs shall be fully vested on May 19, 2025, subject to the continued service of the Reporting Person to the Issuer through each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs do not expire; they either vest or are canceled prior to vest date."}],"balance_after":253125,"derivative":{"underlying":"Common Stock","underlying_shares":28125},"source":{"system":"sec-edgar","filing":"0001209191-23-016513","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000120919123016513/doc4.xml","form_type":"4"}},{"id":1968395,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20769,"kind":"person","name":"Guerard Frederic","position":1,"cik":"0001825009","reported_name":"Guerard Frederic","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-03-07T00:02:23.000Z","date":"2023-03-03","kind":"tax_withholding","acquired":false,"shares":89344,"price":0.57,"value":50926.08,"ownership":{"direct":true},"balance_after":383682,"source":{"system":"sec-edgar","filing":"0001209191-23-016513","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000120919123016513/doc4.xml","form_type":"4"}},{"id":1968394,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20769,"kind":"person","name":"Guerard Frederic","position":1,"cik":"0001825009","reported_name":"Guerard Frederic","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-03-07T00:02:23.000Z","date":"2023-03-03","kind":"exercise","acquired":true,"shares":315496,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":473026,"source":{"system":"sec-edgar","filing":"0001209191-23-016513","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000120919123016513/doc4.xml","form_type":"4"}},{"id":2099774,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20769,"kind":"person","name":"Guerard Frederic","position":1,"cik":"0001825009","reported_name":"Guerard Frederic","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2022-12-01T21:49:51.000Z","date":"2022-12-01","kind":"exercise","acquired":false,"shares":28125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested as to 1/4 of the total shares on May 19, 2022, and 1/16 of the remaining shares shall vest quarterly thereafter such that the RSUs shall be fully vested on May 19, 2025, subject to the continued service of the Reporting Person to the Issuer through each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs do not expire; they either vest or are canceled prior to vest date."}],"balance_after":281250,"derivative":{"underlying":"Common Stock","underlying_shares":28125},"source":{"system":"sec-edgar","filing":"0001209191-22-059205","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000120919122059205/doc4.xml","form_type":"4"}},{"id":2099773,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20769,"kind":"person","name":"Guerard Frederic","position":1,"cik":"0001825009","reported_name":"Guerard Frederic","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-12-01T21:49:51.000Z","date":"2022-12-01","kind":"tax_withholding","acquired":false,"shares":11068,"price":0.63,"value":6972.84,"ownership":{"direct":true},"balance_after":157530,"source":{"system":"sec-edgar","filing":"0001209191-22-059205","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000120919122059205/doc4.xml","form_type":"4"}},{"id":2099772,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20769,"kind":"person","name":"Guerard Frederic","position":1,"cik":"0001825009","reported_name":"Guerard Frederic","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-12-01T21:49:51.000Z","date":"2022-12-01","kind":"exercise","acquired":true,"shares":28125,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":168598,"source":{"system":"sec-edgar","filing":"0001209191-22-059205","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000120919122059205/doc4.xml","form_type":"4"}},{"id":2102196,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20769,"kind":"person","name":"Guerard Frederic","position":1,"cik":"0001825009","reported_name":"Guerard Frederic","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2022-11-29T21:36:44.000Z","date":"2022-11-24","kind":"exercise","acquired":false,"shares":65625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs shall vested as to 6.25% of the total shares on November 16, 2022, and 6.25% of the remaining shares shall vest quarterly thereafter such that the RSUs shall be fully vested on August 16, 2026, subject to the continued service of the Reporting Person to the Issuer through each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs do not expire; they either vest or are canceled prior to vest date."}],"balance_after":984375,"derivative":{"underlying":"Common Stock","underlying_shares":65625},"source":{"system":"sec-edgar","filing":"0001209191-22-058949","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000120919122058949/doc4.xml","form_type":"4"}},{"id":2102195,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20769,"kind":"person","name":"Guerard Frederic","position":1,"cik":"0001825009","reported_name":"Guerard Frederic","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-11-29T21:36:44.000Z","date":"2022-11-24","kind":"tax_withholding","acquired":false,"shares":25824,"price":0.67,"value":17302.08,"ownership":{"direct":true},"balance_after":140473,"source":{"system":"sec-edgar","filing":"0001209191-22-058949","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000120919122058949/doc4.xml","form_type":"4"}},{"id":2102194,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20769,"kind":"person","name":"Guerard Frederic","position":1,"cik":"0001825009","reported_name":"Guerard Frederic","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-11-29T21:36:44.000Z","date":"2022-11-24","kind":"exercise","acquired":true,"shares":65625,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":166297,"source":{"system":"sec-edgar","filing":"0001209191-22-058949","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000120919122058949/doc4.xml","form_type":"4"}},{"id":2172660,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20769,"kind":"person","name":"Guerard Frederic","position":1,"cik":"0001825009","reported_name":"Guerard Frederic","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2022-08-26T20:48:30.000Z","date":"2022-08-24","kind":"grant","acquired":true,"shares":1050000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs shall vest as to 6.25% of the total shares on November 16, 2022, and 6.25% of the remaining shares shall vest quarterly thereafter such that the RSUs shall be fully vested on August 16, 2026, subject to the continued service of the Reporting Person to the Issuer through each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs do not expire; they either vest or are canceled prior to vest date."}],"balance_after":1050000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":1050000},"source":{"system":"sec-edgar","filing":"0001209191-22-047722","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000120919122047722/doc4.xml","form_type":"4"}},{"id":2175851,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20769,"kind":"person","name":"Guerard Frederic","position":1,"cik":"0001825009","reported_name":"Guerard Frederic","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2022-08-23T21:15:52.000Z","date":"2022-08-19","kind":"exercise","acquired":false,"shares":28125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested as to 1/4 of the total shares on May 19, 2022, and 1/16 of the remaining shares shall vest quarterly thereafter such that the RSUs shall be fully vested on May 19, 2025, subject to the continued service of the Reporting Person to the Issuer through each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs do not expire; they either vest or are canceled prior to vest date."}],"balance_after":309375,"derivative":{"underlying":"Common Stock","underlying_shares":28125},"source":{"system":"sec-edgar","filing":"0001209191-22-047229","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000120919122047229/doc4.xml","form_type":"4"}},{"id":2175850,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20769,"kind":"person","name":"Guerard Frederic","position":1,"cik":"0001825009","reported_name":"Guerard Frederic","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-08-23T21:15:52.000Z","date":"2022-08-19","kind":"tax_withholding","acquired":false,"shares":6596,"price":0.97,"value":6398.12,"ownership":{"direct":true},"balance_after":100672,"source":{"system":"sec-edgar","filing":"0001209191-22-047229","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000120919122047229/doc4.xml","form_type":"4"}},{"id":2175849,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20769,"kind":"person","name":"Guerard Frederic","position":1,"cik":"0001825009","reported_name":"Guerard Frederic","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-08-23T21:15:52.000Z","date":"2022-08-19","kind":"exercise","acquired":true,"shares":28125,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":107268,"source":{"system":"sec-edgar","filing":"0001209191-22-047229","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000120919122047229/doc4.xml","form_type":"4"}},{"id":2259526,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20769,"kind":"person","name":"Guerard Frederic","position":1,"cik":"0001825009","reported_name":"Guerard Frederic","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2022-05-23T20:46:15.000Z","date":"2022-05-19","kind":"exercise","acquired":false,"shares":112500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested as to 1/4 of the total shares on May 19, 2022, and 1/16 of the remaining shares shall vest quarterly thereafter such that the RSUs shall be fully vested on May 19, 2025, subject to the continued service of the Reporting Person to the Issuer through each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs do not expire; they either vest or are canceled prior to vest date."}],"balance_after":337500,"derivative":{"underlying":"Common Stock","underlying_shares":112500},"source":{"system":"sec-edgar","filing":"0001209191-22-031348","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000120919122031348/doc4.xml","form_type":"4"}},{"id":2259525,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20769,"kind":"person","name":"Guerard Frederic","position":1,"cik":"0001825009","reported_name":"Guerard Frederic","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-05-23T20:46:15.000Z","date":"2022-05-19","kind":"tax_withholding","acquired":false,"shares":33357,"price":0.9011,"value":30057.9927,"ownership":{"direct":true},"balance_after":79143,"source":{"system":"sec-edgar","filing":"0001209191-22-031348","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000120919122031348/doc4.xml","form_type":"4"}},{"id":2259524,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20769,"kind":"person","name":"Guerard Frederic","position":1,"cik":"0001825009","reported_name":"Guerard Frederic","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-05-23T20:46:15.000Z","date":"2022-05-19","kind":"exercise","acquired":true,"shares":112500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":112500,"source":{"system":"sec-edgar","filing":"0001209191-22-031348","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000120919122031348/doc4.xml","form_type":"4"}},{"id":2359474,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20769,"kind":"person","name":"Guerard Frederic","position":1,"cik":"0001825009","reported_name":"Guerard Frederic","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2022-03-02T23:56:41.000Z","date":"2022-02-28","kind":"grant","acquired":true,"shares":221746,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs shall vests as to 100% of the total RSUs on February 28, 2023, subject to the Reporting Person's provision of service to the Issuer on the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs shall vests as to 100% of the total RSUs on February 28, 2023, subject to the Reporting Person's provision of service to the Issuer on the vesting date."}],"balance_after":221746,"derivative":{"underlying":"Common Stock","underlying_shares":221746},"source":{"system":"sec-edgar","filing":"0001209191-22-015050","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000120919122015050/doc4.xml","form_type":"4"}},{"id":2359473,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20769,"kind":"person","name":"Guerard Frederic","position":1,"cik":"0001825009","reported_name":"Guerard Frederic","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-03-02T23:56:41.000Z","date":"2022-02-28","kind":"grant","acquired":true,"shares":170054,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 100% of the total shares on February 28, 2023, subject to the Reporting Person's provision of service to the Issuer on the vesting date."}],"balance_after":170054,"derivative":{"exercise_price":1.33,"expiration_date":"2032-02-27","underlying":"Common Stock","underlying_shares":170054},"source":{"system":"sec-edgar","filing":"0001209191-22-015050","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000120919122015050/doc4.xml","form_type":"4"}},{"id":2700368,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20769,"kind":"person","name":"Guerard Frederic","position":1,"cik":"0001825009","reported_name":"Guerard Frederic","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2021-05-21T20:25:28.000Z","date":"2021-05-19","kind":"grant","acquired":true,"shares":450000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs shall vest as to 1/4 of the total shares on May 19, 2022, and 1/16 of the remaining shares shall vest quarterly thereafter such that the RSUs shall be fully vested on May 19, 2025, subject to the continued service of the Reporting Person to the Issuer through each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs do not expire; they either vest or are canceled prior to vest date."}],"balance_after":450000,"derivative":{"underlying":"Common Stock","underlying_shares":450000},"source":{"system":"sec-edgar","filing":"0001209191-21-034912","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000120919121034912/doc4.xml","form_type":"4"}},{"id":2700367,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20769,"kind":"person","name":"Guerard Frederic","position":1,"cik":"0001825009","reported_name":"Guerard Frederic","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-05-21T20:25:28.000Z","date":"2021-05-19","kind":"grant","acquired":true,"shares":660000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 1/4 of the total shares on May 19, 2022 and then 1/48 of the total shares monthly until the option is fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":660000,"derivative":{"exercise_price":3.73,"expiration_date":"2031-05-18","underlying":"Common Stock","underlying_shares":660000},"source":{"system":"sec-edgar","filing":"0001209191-21-034912","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000120919121034912/doc4.xml","form_type":"4"}},{"id":2949779,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20769,"kind":"person","name":"Guerard Frederic","position":1,"cik":"0001825009","reported_name":"Guerard Frederic","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-12-10T22:09:54.000Z","date":"2020-12-08","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 1/48 of the total shares on January 8, 2021 and each month thereafter until option is fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":200000,"derivative":{"exercise_price":23.66,"expiration_date":"2030-12-07","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001209191-20-062752","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000120919120062752/doc4.xml","form_type":"4"}}]}